文献速递前列腺癌

认知前列腺穿刺活检中绘图策略的有效性:一项前瞻性随机研究

Effectiveness of Mapping for Cognitive Prostate Biopsy: A Prospective, Randomized Study.
PubMed 文献 · Urology · 2025-03-22

该前瞻性随机研究将155例接受多参数前列腺磁共振成像(mpMRI)的患者按1:1分为前列腺绘图组和标准组,评估在mpMRI报告中附加简单前列腺示意图对认知靶向穿刺活检诊断效能的影响。结果显示,绘图组总体癌症检出率57%、标准组35%(P=.006),临床显著前列腺癌(csPCa)检出率分别为47%(36/77)和21%(16/78)(P<.001),仅靶向穿刺的csPCa检出率在绘图组高达3倍(17% vs 6%,P=.048)。作者强烈推荐在活检方案中使用示意图绘图。

要点

  • 绘图组总体癌症检出率57% vs 标准组35%(P=.006)。
  • 绘图组csPCa检出率47%(36/77)vs 标准组21%(16/78)(P<.001)。
  • 仅靶向穿刺的csPCa检出率绘图组17% vs 标准组6%(P=.048)。

核心结论

  • 在mpMRI报告中附加简单绘图策略可显著提高认知穿刺活检的癌症检出率。
  • 作者强烈推荐在活检方案中使用示意图绘图。

研究设计与样本

  • 前瞻性随机研究,共纳入155例接受mpMRI作为标准诊疗的患者,按1:1随机分为前列腺绘图组和标准组。
  • 绘图组由单一专科泌尿放射科医生在示意图上绘制可疑病灶(≥PI-RADS 3),两组均由单一经验丰富的泌尿外科医生对每个目标取4针靶向穿刺加12针系统穿刺。
  • 以Gleason评分3+4或更高定义为临床显著前列腺癌(csPCa)。

主要发现

  • 绘图组与标准组总体癌症检出率分别为57%和35%,差异有统计学意义(P=.006)。
  • 绘图组csPCa检出率为47%(36/77),标准组为21%(16/78),差异有统计学意义(P<.001)。
  • 仅靶向穿刺的csPCa检出率绘图组为17%,标准组为6%,绘图组约为标准组的3倍(P=.048)。

临床怎么用

  • 作者强烈推荐在活检方案中使用示意图绘图。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the efficacy of adding a simple prostate mapping diagram to multiparametric prostate magnetic resonance imaging (mpMRI) reports, a randomized, prospective study is designed. Despite cognitive prostate biopsy is the most preferred approach among targeted biopsy methods due to its low cost and easy application, its operator dependency requires standardization to improve diagnostic accuracy for prostate cancer (PCa). METHODS: A total of 155 patients underwent mpMRI as the standard of care and were randomly assigned in a 1:1 ratio to two groups: prostate mapping diagram and standard group. In addition to the mpMRI reports, suspicious lesions (≥PI-RADS 3) were drawn on a schematic diagram by a single specialized uro-radiologist in the prostate mapping group. A single experienced urologist sampled four cores from each target in addition to a 12-core systematic biopsy in both groups. A Gleason score of 3+4 or higher was considered as clinically significant PCa (csPCa). RESULTS: Overall cancer detection rate between the group 1 and 2 was statistically significant (57% and 35%, respectively, P=.006). Particularly, csPCa rates among the groups were 47% (36/77) and 21% (16/78) for group 1 and group 2, respectively (P<.001). The csPCa detection with only targeted biopsies was strikingly as high as 3-fold (17% vs 6%, P=.048) in the mapping group. CONCLUSION: Our prospective study has shown that the addition of a simple mapping strategy to mpMRI reports significantly increased cancer rates by cognitive biopsy. We strongly recommend the use of a schematic mapping diagram in biopsy protocols.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Kars M, Cimsit C, Genc YE, et al. Effectiveness of Mapping for Cognitive Prostate Biopsy: A Prospective, Randomized Study. Urology. 2025. PMID: 40127771. doi:10.1016/j.urology.2025.03.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。